-+ 0.00%
-+ 0.00%
-+ 0.00%

Veeva (VEEV) Stock Looks Strong On Cash Flow While Earnings Look Rich

Simply Wall St·08/11/2026 10:27:38
Listen to the news

Veeva Systems stock presents a clear valuation split today. The intrinsic value estimate based on a Discounted Cash Flow (DCF) view points to upside relative to the current share price, while market multiples suggest the stock already trades at a premium.

  • Over the past 5 years, Veeva Systems has delivered a decline of 26.5% which raises questions about how much improvement is already reflected in the current price.
  • Expectations that Veeva Systems can continue converting its software model into steady cash flows may support the DCF view, while any slowdown in growth or pressure on margins could leave a premium multiple exposed.
  • Across Simply Wall St's broader checks, Veeva Systems screens as a mixed picture rather than a clear bargain or clear overvaluation, with the stock passing 3 of 6 tests on its value score.

The issue now is whether investors should give more weight to the DCF based intrinsic value estimate that points to undervaluation, or to the richer market multiples that imply Veeva Systems is already priced for strong execution.

Veeva Systems delivered -15.3% returns over the last year. See how this stacks up to the rest of the Healthcare Services industry.

Is Veeva Systems Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach looks at the cash Veeva Systems can generate for shareholders in the future and then brings those cash flows back to today. For Veeva Systems, the model uses latest twelve month free cash flow of about $1.64b and assumes that cash flows continue growing from this base rather than reversing or shrinking.

Based on these assumptions, the DCF points to an estimated intrinsic value of about $303 per share. Compared with the current share price, this implies the stock trades at roughly a 22.5% discount to the cash flow based estimate. This difference suggests the market is pricing Veeva Systems more cautiously than the model, despite the company already generating substantial free cash flow in absolute terms.

On this cash flow view, Veeva Systems stock currently appears undervalued.

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 22.5%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

VEEV Discounted Cash Flow as at Aug 2026
VEEV Discounted Cash Flow as at Aug 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Veeva Systems.

Has Veeva Systems Run Too Far on Earnings?

P/E fits Veeva Systems well because the company is already profitable and investors often anchor on earnings for software and healthcare related businesses. On this metric, Veeva Systems trades at about 40.5x earnings, which is above the Healthcare Services industry average of roughly 28.7x and below the peer group average near 55.8x.

The fair P/E ratio implied by Simply Wall St's model is about 31.3x. That is lower than the current 40.5x, which indicates the stock carries a premium even after accounting for its specific growth profile, margins, size and risk factors. While Veeva Systems does not sit at the very top of its peer range, the current P/E suggests investors are already paying up for execution and quality relative to what the model treats as a more balanced earnings multiple.

On the P/E view, Veeva Systems stock currently screens as overvalued relative to its modelled fair earnings multiple.

NYSE:VEEV P/E Ratio as at Aug 2026
NYSE:VEEV P/E Ratio as at Aug 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Veeva Systems Narrative: What Would Justify Today's Price?

Simply Wall St Narratives try to bridge Veeva Systems' valuation puzzle by spelling out which paths for growth, margins and earnings would need to play out for the stock to be worth materially more or less than it is today. Each narrative connects its number to a clear view on how Veeva Systems' growth, profitability and risks could evolve. This gives you a reference point you can revisit as fresh results and new information come through. Narratives sit on Simply Wall St's Community page and are intended as a structured way to compare different, clearly stated assumptions about the company.

The community is split on Veeva Systems, with one camp seeing resilient compounding potential and the other focusing on valuation and disruption risk.

Bull case: 27% undervalued

"Veeva’s advantage is not that it invented AI. Its advantage may be that it already owns the workflow layer where AI can become useful…"

Read the full Bull Case to see why Veeva Systems could be undervalued

Bear case: 42% overvalued

"Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high…"

Read the full Bear Case to see why Veeva Systems could be overvalued

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

The Bottom Line

Veeva Systems sits between two readings. The Discounted Cash Flow (DCF) view points to undervaluation based on its current cash generation and assumed cash flow path, while the market multiple view flags the stock as overvalued on earnings compared with a modelled fair P/E. That gap largely comes down to differing expectations for how much growth and profitability investors are willing to pay for today. The key question from here is whether Veeva Systems can deliver the earnings and margin profile that keeps its richer P/E intact, rather than seeing the multiple settle closer to the intrinsic value estimate.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.